Senior pharmaceutical executives discuss the latest hot topics, which facilitate dialogue and networking between peers of industry, solution providers and key decision makers.
NASHVILLE, Tennessee – Representatives from LGM Pharma, a leading supplier of active pharmaceutical ingredients to various global pharmaceutical firms, Headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, will be attending the InformEx 2014 Conference in Miami Beach January 21-24 in order to meet existing clients, network with new potential clients and to keep themselves abreast of the newest industry trends.
InformEx is the only event of its kind offering participants a direct view of what is happening globally across the fine, specialty and custom chemical marketplace. The event brings together an international mix of more than 3,500 motivated buyers and sellers of high value chemistry for four days of sourcing, education and networking.
According to Steve Sicherman, LGM Pharma Marketing Director, “At InformEx our clients will be seeking out partners and relationships for drug development projects. Many contract research companies will be there. We are inviting all those interested to come to our Booth #233.”
In September 2013 LGM Pharma representatives attended Contract Pharma’s 12th Annual Contracting and Outsourcing Conference and Tabletop Exhibition at the Hyatt Regency in New Brunswick, NJ. The event featured a record-breaking number of attendees, and the sold-out Exhibit Hall was buzzing throughout the one-day exhibition.
“With high-powered presentations and a tabletop exhibition featuring 160 contract service providers and vendors, Contracting and Outsourcing 2013 was the premier event for Pharma and Biopharma decision makers,” stated Robert Hoppes, LGM Pharma Director of Sales. “We can’t wait for next year’s exhibition.”
LGM Pharma representatives also had a presence in October 2013 at CPhI Worldwide with more than 34,000 attendees and 2,200 exhibitors. Held in Frankfurt, Germany, the show hosted senior level decision makers and key players from more than 140 countries representing every step of the pharmaceutical supply chain from drug discovery to finished dosage.
Mendy Schurder, LGM Pharma COO stated, “The CPhI event has become the world’s melting pot and key point of the year to complete new deals, see innovative technologies and meet potential partners. It’s invaluable to the industry.”
“As part of our ongoing commitment to driving growth and innovation in the global pharmaceutical market, CPhI provides an efficient and effective platform for the most active buyers to identify business opportunities and meet with potential partners to move the industry forward,” commented CPhI Portfolio Director, Greg Kerwin. “Despite global economic uncertainly, we are enthused to see such optimism and focus on innovation from the leaders in the pharmaceutical industry.”
About LGM Pharma
LGM Pharma is a leading supplier of active pharmaceutical ingredients (APIs) to Contract manufacturers and various global pharmaceutical firms involved in the manufacturing, research and development of a wide range of therapeutic chemical entities. In its commitment to improving health opportunities all over the world, LGM Pharma has forged partnerships with some of the biggest names in the pharmaceutical industry. Currently, the company supplies over 2,500 active pharmaceutical ingredients to its global clients.